CN103110838B - 一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 - Google Patents
一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 Download PDFInfo
- Publication number
- CN103110838B CN103110838B CN201310050384.3A CN201310050384A CN103110838B CN 103110838 B CN103110838 B CN 103110838B CN 201310050384 A CN201310050384 A CN 201310050384A CN 103110838 B CN103110838 B CN 103110838B
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- chinese medicine
- acute mastitis
- type acute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 208000004396 mastitis Diseases 0.000 title claims abstract description 30
- 239000006210 lotion Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000000391 smoking effect Effects 0.000 title abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 25
- 241000628997 Flos Species 0.000 claims abstract description 19
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 7
- 241001643642 Viticis Species 0.000 claims abstract description 7
- 241001113925 Buddleja Species 0.000 claims abstract 2
- 241000931705 Cicada Species 0.000 claims abstract 2
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 6
- 241001505096 Rhamnus davurica Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003643 water by type Substances 0.000 claims description 3
- 241000592346 Ginkgophyta Species 0.000 claims 1
- 235000014435 Mentha Nutrition 0.000 claims 1
- 241001072983 Mentha Species 0.000 claims 1
- 241000283898 Ovis Species 0.000 claims 1
- 235000004347 Perilla Nutrition 0.000 claims 1
- 241000229722 Perilla <angiosperm> Species 0.000 claims 1
- 241000207929 Scutellaria Species 0.000 claims 1
- 240000006694 Stellaria media Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 241000099774 Cuscuta salina Species 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 abstract 1
- 241000512005 Alstonia Species 0.000 abstract 1
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 235000015763 Artemisia ludoviciana Nutrition 0.000 abstract 1
- 244000062995 Cassia occidentalis Species 0.000 abstract 1
- 235000001948 Cassia occidentalis Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000490229 Eucephalus Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000608847 Gnaphalium Species 0.000 abstract 1
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 244000050427 Melilotus officinalis subsp suaveolens Species 0.000 abstract 1
- 235000000839 Melilotus officinalis subsp suaveolens Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241001262059 Meretrix Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000007019 Oxalis corniculata Species 0.000 abstract 1
- 235000016499 Oxalis corniculata Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 241000219100 Rhamnaceae Species 0.000 abstract 1
- 241000681946 Rhododendron dauricum Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001302210 Sida <water flea> Species 0.000 abstract 1
- 240000007641 Spergula rubra Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241001278775 Veronicastrum Species 0.000 abstract 1
- 240000004922 Vigna radiata Species 0.000 abstract 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 abstract 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 abstract 1
- 241000107360 Vincetoxicum glaucescens Species 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 235000005221 swamp mahogany Nutrition 0.000 abstract 1
- 244000239645 swamp mahogany Species 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 42
- 210000004185 liver Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 18
- 210000002784 stomach Anatomy 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 14
- 208000026435 phlegm Diseases 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 13
- 208000004880 Polyuria Diseases 0.000 description 12
- 230000035619 diuresis Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 11
- 210000000481 breast Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 210000002429 large intestine Anatomy 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000218628 Ginkgo Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000001174 ascending effect Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000024818 Nipple disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010038944 Retracted nipple Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- UBYZFUSXTLJWFM-UHFFFAOYSA-N grandis-3 Natural products O=C1C(C)(C)C(=O)C(C)(C)C2(O)C1=CC(C)(C)OO2 UBYZFUSXTLJWFM-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
年龄(岁) | 25~27 | 28~30 | 31~32 | 33~37 |
例数 | 231 | 52 | 98 | 5 |
百分比 | 59.8% | 13.5% | 25.4% | 1.3% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 383 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
治疗天数 | 3~5 | 6~9 | 10~14 | 15~21 |
例数 | 23 | 265 | 91 | 7 |
百分比 | 6% | 68.7% | 23.5% | 1.8% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310050384.3A CN103110838B (zh) | 2013-02-09 | 2013-02-09 | 一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310050384.3A CN103110838B (zh) | 2013-02-09 | 2013-02-09 | 一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103110838A CN103110838A (zh) | 2013-05-22 |
CN103110838B true CN103110838B (zh) | 2014-04-02 |
Family
ID=48409245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310050384.3A Expired - Fee Related CN103110838B (zh) | 2013-02-09 | 2013-02-09 | 一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103110838B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251782A (zh) * | 2013-05-25 | 2013-08-21 | 韩增禄 | 一种治疗吸烟型贲门炎的中药制备方法 |
CN103251781A (zh) * | 2013-05-25 | 2013-08-21 | 刘国利 | 一种治疗嗜食大蒜型贲门炎的中药制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102319374A (zh) * | 2011-09-28 | 2012-01-18 | 王爱芹 | 一种治疗咳嗽型褥疮的中药洗剂制备方法 |
-
2013
- 2013-02-09 CN CN201310050384.3A patent/CN103110838B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102319374A (zh) * | 2011-09-28 | 2012-01-18 | 王爱芹 | 一种治疗咳嗽型褥疮的中药洗剂制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103110838A (zh) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110797B (zh) | 一种治疗肿胀型急性乳腺炎的中药洗剂制备方法 | |
CN102743633B (zh) | 一种治疗腐肉型蜂窝组织炎的中药洗剂制备方法 | |
CN102579824A (zh) | 一种治疗嗜食辣椒型臁疮的中药洗剂制备方法 | |
CN103110838B (zh) | 一种治疗吸烟型急性乳腺炎的中药洗剂制备方法 | |
CN103099934B (zh) | 一种治疗气滞血瘀型急性乳腺炎的中药洗剂制备方法 | |
CN102743613B (zh) | 一种治疗胃阴亏虚型老年性***炎的中药洗剂制备方法 | |
CN103110856A (zh) | 一种治疗发热型急性乳腺炎的中药洗剂制备方法 | |
CN103099989A (zh) | 一种治疗乳汁郁积型急性乳腺炎的中药洗剂制备方法 | |
CN103099960A (zh) | 一种治疗胃热型急性乳腺炎的中药洗剂制备方法 | |
CN103100009B (zh) | 一种治疗乳管痹阻型急性乳腺炎的中药洗剂制备方法 | |
CN102743620B (zh) | 一种治疗热毒型慢性子***的中药冲洗剂制备方法 | |
CN103099990A (zh) | 一种治疗结块型急性乳腺炎的中药洗剂制备方法 | |
CN103100054A (zh) | 一种治疗疼痛型急性乳腺炎的中药洗剂制备方法 | |
CN104623612A (zh) | 一种治疗乳痈的活血化瘀药及制备方法 | |
CN103110893A (zh) | 一种治疗热毒型急性乳腺炎的中药洗剂制备方法 | |
CN102743719B (zh) | 一种治疗中气不足型老年性***炎的中药洗剂制备方法 | |
CN102743597B (zh) | 一种治疗盗汗型滴虫性***炎的中药洗剂制备方法 | |
CN102631576B (zh) | 一种治疗便秘型足底疔的中药洗剂制备方法 | |
CN103099991A (zh) | 一种治疗嗜食大蒜型急性乳腺炎的中药洗剂制备方法 | |
CN103100001B (zh) | 一种治疗酗酒型急性乳腺炎的中药洗剂制备方法 | |
CN103099987A (zh) | 一种治疗嗜食辣椒型急性乳腺炎的中药洗剂制备方法 | |
CN102743571B (zh) | 一种治疗吸烟型霉菌性***炎的中药洗剂制备方法 | |
CN104784563A (zh) | 一种治疗扁桃体炎的中药制剂及其制备方法 | |
CN102631546B (zh) | 一种治疗嗜食芥末型臁疮的中药洗剂制备方法 | |
CN102743649B (zh) | 一种治疗***脓水型霉菌性***炎的中药洗剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XU XIUYUN Free format text: FORMER OWNER: YUAN YUCHAO Effective date: 20140219 |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Xiuyun Inventor after: Sun Shufeng Inventor before: Yuan Yuchao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YUAN YUCHAO TO: XU XIUYUN SUN SHUFENG Free format text: CORRECT: ADDRESS; FROM: 250200 JINAN, SHANDONG PROVINCE TO: 252652 LIAOCHENG, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140219 Address after: 252652 Linqing pine Center Health Center, Linqing, Shandong, Liaocheng Applicant after: Xu Xiuyun Address before: 250200 Zhangqiu people's Hospital, Ji'nan, Shandong Applicant before: Yuan Yuchao |
|
TA01 | Transfer of patent application right | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20150209 |
|
EXPY | Termination of patent right or utility model |